Miranda Morton

Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trial

I. Pedley, S. Crabb, E. Clark, 2022, NIHR open research.

Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol

D. Howel, J. Staffurth, I. Pedley, 2019, BMJ Open.

Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial

J. Isaacs, C. Yap, M. Cole, 2021, The Lancet. Rheumatology.

Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition

J. Isaacs, M. Cole, D. Stocken, 2020, Medicine.

Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasis

J. Wason, C. Haworth, A. Hill, 2023, BMJ open.

AB0356 TARGETING THE RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLAST VIA CYCLIN DEPENDENT KINASE INHIBITION (TRAFIC): A PHASE 1B STUDY TO DETERMINE THE MAXIMUM TOLERATED DOSE OF SELICICLIB FOR REPURPOSING IN RHEUMATOID ARTHRITIS

J. Isaacs, D. Stocken, I. McInnes, 2020 .